Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Nasser Alhajj, Chin Fei Chee, Tin Wui Wong, Noorsaadah Abd Rahman, Noor Hayaty Abu Kasim & Paolo Colombo. (2018) Lung cancer: active therapeutic targeting and inhalational nanoproduct design. Expert Opinion on Drug Delivery 15:12, pages 1223-1247.
Read now
Read now
Ying Liu, Xian-hong Liu, Ying Wang, Jing Zhu, Ying Xin, Kai Niu, Sheng Wang & Ying Cheng. (2017) A study on different therapies and prognosis-related factors for 101 patients with SCLC and brain metastases. Cancer Biology & Therapy 18:9, pages 670-675.
Read now
Read now
Gerhard Hamilton, Maximilian Hochmair, Barbara Rath, Lukas Klameth & Robert Zeillinger. (2016) Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype . Cell Adhesion & Migration 10:4, pages 360-367.
Read now
Read now
Gerhard Hamilton, Barbara Rath, Lukas Klameth & Maximilan J. Hochmair. (2016) Small cell lung cancer: Recruitment of macrophages by circulating tumor cells. OncoImmunology 5:3.
Read now
Read now
Xiaoguang Xiao, Shujing Wang, Shu Xia, Man Zou, Yang Li, Yao Wei, Qi Mei & Yuan Chen. (2015) Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer. OncoTargets and Therapy 8, pages 2209-2214.
Read now
Read now
Articles from other publishers (33)
Ming-Chun Hung, Wan-Ping Wang & Ya-Hui Chi. (2022) AKT phosphorylation as a predictive biomarker for PI3K/mTOR dual inhibition-induced proteolytic cleavage of mTOR companion proteins in small cell lung cancer. Cell & Bioscience 12:1.
Crossref
Crossref
Raphael Hagmann, Alfred Zippelius & Sacha I. Rothschild. (2022) Validation of Pretreatment Prognostic Factors and Prognostic Staging Systems for Small Cell Lung Cancer in a Real-World Data Set. Cancers 14:11, pages 2625.
Crossref
Crossref
Alejandro Cardona-Monzonís, Ángel L. Ortega, Julian Carretero, José Luis García-Giménez & Salvador Mena-Mollá. 2022. Epigenetics in Precision Medicine. Epigenetics in Precision Medicine
109
145
.
Benjamin J. Drapkin & Charles M. Rudin. (2021) Advances in Small-Cell Lung Cancer (SCLC) Translational Research. Cold Spring Harbor Perspectives in Medicine 11:4, pages a038240.
Crossref
Crossref
Sarah Sharman Moser, Jair Bar, Inna Kan, Keren Ofek, Raanan Cohen, Nikhil Khandelwal, Varda Shalev, Gabriel Chodick & Nava Siegelmann-Danieli. (2021) Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes. Current Oncology 28:1, pages 317-331.
Crossref
Crossref
Zoltan Lohinai, Zsolt Megyesfalvi, Balazs Dome & Glen J. Weiss. (2019) Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC). Translational Oncology 12:12, pages 1539-1548.
Crossref
Crossref
Xiaoling Shang, Jiamao Lin, Zhenxiang Li & Haiyong Wang. (2019) Radiotherapy may improve survival of ES‑SCLC with distant metastasis only for patients with one metastatic site: A population‑based study. Oncology Letters.
Crossref
Crossref
Qianqian Duan, Dan Li, Lipeng Xiong, Zenghui Chang & Guoqiang Xu. (2019) SILAC Quantitative Proteomics and Biochemical Analyses Reveal a Novel Molecular Mechanism by Which ADAM12S Promotes the Proliferation, Migration, and Invasion of Small Cell Lung Cancer Cells through Upregulating Hexokinase 1. Journal of Proteome Research 18:7, pages 2903-2914.
Crossref
Crossref
Florent Puisset, Laurence Bigay-Game, Marie Noëlle Paludetto, Audrey Martel, Sophie Perriat, Audrey Rabeau, Jean Marie Canonge & Julien Mazieres. (2018) Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit. Supportive Care in Cancer 27:5, pages 1679-1686.
Crossref
Crossref
Zongqiang Wang, Guifeng Liu & Jinlan Jiang. (2019) Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture. International Journal of Oncology.
Crossref
Crossref
Femke M. de Man, Andrew K. L. Goey, Ron H. N. van Schaik, Ron H. J. Mathijssen & Sander Bins. (2018) Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics. Clinical Pharmacokinetics 57:10, pages 1229-1254.
Crossref
Crossref
Jennifer L Bryant, Roben G Gieling, Suzanne L Meredith, Tiffany-Jayne Allen, Leanne Walker, Brian A Telfer, Claudiu T Supuran, Kaye J Williams & Anne White. (2018) Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer. International Journal of Cancer 142:1, pages 191-201.
Crossref
Crossref
Katherina Bernadette Sreter, Blazenka Barisic, Marija Barisic Kutija, Suzana Kukulj & Miroslav Samarzija. (2017) Synchronous Adie's syndrome and type 1 antineuronal nuclear antibody (anti-Hu)-related paraneoplastic neurological syndromes as predictors of complete response in limited-stage small-cell lung cancer: A case report. Molecular and Clinical Oncology 6:6, pages 921-924.
Crossref
Crossref
Shuncong Wang, Jianjun Tang, Tiantian Sun, Xiaobin Zheng, Jie Li, Hongliu Sun, Xiuling Zhou, Cuiling Zhou, Hongyu Zhang, Zhibin Cheng, Haiqing Ma & Huanhuan Sun. (2017) Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages. Scientific Reports 7:1.
Crossref
Crossref
Pramod K. Julka, Daya Nand Sharma, Renu Madan, Supriya Mallick, Rony Benson, Haresh Kunhi P, Subhash Gupta & Goura K. Rath. (2017) Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India. Journal of the Egyptian National Cancer Institute 29:1, pages 47-51.
Crossref
Crossref
Sue-Ming Chang, Wilson Christian, Ming-Hsi Wu, Tai-Lin Chen, Yi-Wen Lin, Ching-Shu Suen, Hima Bindu Pidugu, Dilip Detroja, Anamik Shah, Ming-Jing Hwang, Tsann-Long Su & Te-Chang Lee. (2017) Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities. European Journal of Medicinal Chemistry 127, pages 235-249.
Crossref
Crossref
XinGang Lu, Liu Yang, JingXian Chen, JiAn Zhou, XiaoDan Tang, YingGang Zhu, HongFu Qiu & Jie Shen. (2016) The action and mechanism of myrislignan on A549 cells in vitro and in vivo. Journal of Natural Medicines 71:1, pages 76-85.
Crossref
Crossref
Gerhard Hamilton & Barbara Rath. 2017. Isolation and Molecular Characterization of Circulating Tumor Cells. Isolation and Molecular Characterization of Circulating Tumor Cells
229
245
.
XinGang Lu, HongFu Qiu, Liu Yang, JieYing Zhang, ShuJie Ma & Lan Zhen. (2016) Anti-proliferation effects, efficacy of cyasterone in vitro and in vivo and its mechanism. Biomedicine & Pharmacotherapy 84, pages 330-339.
Crossref
Crossref
Omar Mahmoud, Deukwoo Kwon, Brad Greenfield, Jean L. Wright & Michael A. Samuels. (2016) Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database. International Journal of Clinical Oncology 21:6, pages 1062-1070.
Crossref
Crossref
Liang Gong, Xiangdong Zhou, Jingxiang Yang, Yongyuan Jiang & Heping Yang. (2016) Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells. Oncology Reports.
Crossref
Crossref
Yusuke Ogitani, Tetsuo Aida, Katsunobu Hagihara, Junko Yamaguchi, Chiaki Ishii, Naoya Harada, Masako Soma, Hiromi Okamoto, Masataka Oitate, Shingo Arakawa, Takehiro Hirai, Ryo Atsumi, Takashi Nakada, Ichiro Hayakawa, Yuki Abe & Toshinori Agatsuma. (2016) DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1. Clinical Cancer Research 22:20, pages 5097-5108.
Crossref
Crossref
Yusuke Ogitani, Yuki Abe, Takuma Iguchi, Junko Yamaguchi, Tomoko Terauchi, Michiko Kitamura, Koichi Goto, Mayumi Goto, Masataka Oitate, Hideo Yukinaga, Yoshiyuki Yabe, Takashi Nakada, Takeshi Masuda, Koji Morita & Toshinori Agatsuma. (2016) Wide application of a novel topoisomerase I inhibitor-based drug conjugation technology. Bioorganic & Medicinal Chemistry Letters 26:20, pages 5069-5072.
Crossref
Crossref
G. Hamilton, B. Rath & E. Ulsperger. (2016) A review of the role of surgery for small cell lung cancer and the potential prognostic value of enumeration of circulating tumor cells. European Journal of Surgical Oncology (EJSO) 42:9, pages 1296-1302.
Crossref
Crossref
Min Guo, Guo-Bin Ding, Peng Yang, Lichao Zhang, Haili Wu, Hanqing Li & Zhuoyu Li. (2016)
Migration Suppression of Small Cell Lung Cancer by Polysaccharides from
Nostoc commune
Vaucher
. Journal of Agricultural and Food Chemistry 64:32, pages 6277-6285.
Crossref
Crossref
Zoltan Lohinai, Peter Dome, Zsuzsa Szilagyi, Gyula Ostoros, Judit Moldvay, Balazs Hegedus, Balazs Dome & Glen J. Weiss. (2016) From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC). PLOS ONE 11:1, pages e0144797.
Crossref
Crossref
XinGang Lu, Liu Yang, ChengHua Lu, ZhenYu Xu, HongFu Qiu, JiaJia Wu, JingWen Wang, JiaFeng Tong, Yin Zhu & Jie Shen. (2016)
Molecular Role of EGFR-MAPK Pathway in Patchouli Alcohol-Induced Apoptosis and Cell Cycle Arrest on A549 Cells
In Vitro
and
In Vivo
. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
Paula Lopez-Serra & Juan Sandoval. 2016. Epigenetic Biomarkers and Diagnostics. Epigenetic Biomarkers and Diagnostics
539
555
.
Bingliang Fang, Reza J Mehran, John V Heymach & Stephen G Swisher. (2015) Predictive biomarkers in precision medicine and drug development against lung cancer. Chinese Journal of Cancer 34:3.
Crossref
Crossref
Mee Sook Roh, Ji Hyun Lee, Kyung Woo Kang, Hyun-Yeol Nam, Sang Bong Jung, Kyungeun Kim, Eun Hee Lee, Moon-il Park, Mee-Seon Kim & Hyoun Wook Lee. (2015) Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer. Virchows Archiv 467:6, pages 667-673.
Crossref
Crossref
Man Qiao & Guohua Hu. (2015) Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer. Tumor Biology 36:10, pages 7493-7499.
Crossref
Crossref
Gerhard Hamilton & Barbara Rath. (2015) Smoking, inflammation and small cell lung cancer: recent developments. Wiener Medizinische Wochenschrift 165:19-20, pages 379-386.
Crossref
Crossref
Gonzalo Lopez-Abente, Olivier Nuuez, Beatriz Perez-Gomez, Nuria Aragones & Marina Pollan. (2015) La Situaciin Del CCncer En Espaaa: Informe 2015 (The Situation of Cancer in Spain: Report 2015). SSRN Electronic Journal.
Crossref
Crossref